▶ 調査レポート

自己免疫薬のアメリカ市場2017

• 英文タイトル:United States Autoimmune Drugs Market Report 2017

QYResearchが調査・発行した産業分析レポートです。自己免疫薬のアメリカ市場2017 / United States Autoimmune Drugs Market Report 2017 / A042117552資料のイメージです。• レポートコード:A042117552
• 出版社/出版日:QYResearch / 2017年3月2日
• レポート形態:英文、PDF、121ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥406,600 (USD3,800)▷ お問い合わせ
  Enterprise¥813,200 (USD7,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、自己免疫薬のアメリカ市場について調査・分析し、自己免疫薬のアメリカ市場概観、自己免疫薬の種類別市場分析、用途別市場分析、自己免疫薬のアメリカ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、アメリカ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・自己免疫薬のアメリカ市場概観
・自己免疫薬の種類別市場規模
・自己免疫薬の用途別市場規模
・自己免疫薬のアメリカ市場規模
・自己免疫薬のアメリカ市場予測
・自己免疫薬の製造メーカー分析
・自己免疫薬のメーカー別生産量
・自己免疫薬のメーカー別市場シェア
・自己免疫薬の価格動向・価格分析
・自己免疫薬の販売(売上高)動向
・自己免疫薬の貿易(輸出・輸入)動向
・自己免疫薬の産業チェーン分析
・自己免疫薬のマーケティング戦略分析
・自己免疫薬の販売業者(代理店)リスト
・自己免疫薬の市場環境分析
...

Notes:Sales, means the sales volume of Autoimmune Drugs
Revenue, means the sales value of Autoimmune Drugs

This report studies sales (consumption) of Autoimmune Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
F. Hoffmann-La Roche
AstraZeneca
GSK
Merck
Boehringer Ingelheim
Eli Lilly
Novartis
Sanofi
Takeda Pharmaceuticals
Vertex Pharmaceuticals
Eisai
Lexicon Pharmaceuticals
KaloBios Pharmaceuticals
Can-Fite BioPharma
Antares Pharma
Acorda Therapeutics

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Split by applications, this report focuses on sales, market share and growth rate of Autoimmune Drugs in each application, can be divided into
Hospital
Clinic

レポート目次

Table of Contents

United States Autoimmune Drugs Market Report 2017
1 Autoimmune Drugs Overview
1.1 Product Overview and Scope of Autoimmune Drugs
1.2 Classification of Autoimmune Drugs
1.2.1 Rheumatoid Arthritis (RA)
1.2.2 Multiple Sclerosis (MS)
1.2.3 Psoriasis
1.2.4 Inflammatory Bowel Disease (IBD)
1.2.5 Ankylosing Spondylitis (AS)
1.2.6 Systemic Lupus Erythematosus (SLE)
1.3 Application of Autoimmune Drugs
1.3.1 Hospital
1.3.2 Clinic
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Autoimmune Drugs (2012-2022)
1.4.1 United States Autoimmune Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Autoimmune Drugs Revenue and Growth Rate (2012-2022)

2 United States Autoimmune Drugs Competition by Manufacturers
2.1 United States Autoimmune Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Autoimmune Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Autoimmune Drugs Average Price by Manufactures (2015 and 2016)
2.4 Autoimmune Drugs Market Competitive Situation and Trends
2.4.1 Autoimmune Drugs Market Concentration Rate
2.4.2 Autoimmune Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Autoimmune Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Autoimmune Drugs Sales and Market Share by States (2012-2017)
3.2 United States Autoimmune Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Autoimmune Drugs Price by States (2012-2017)

4 United States Autoimmune Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Autoimmune Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Autoimmune Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Autoimmune Drugs Price by Type (2012-2017)
4.4 United States Autoimmune Drugs Sales Growth Rate by Type (2012-2017)

5 United States Autoimmune Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Autoimmune Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Autoimmune Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Autoimmune Drugs Manufacturers Profiles/Analysis
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Autoimmune Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Johnson & Johnson
6.2.2 Autoimmune Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Johnson & Johnson Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Biogen
6.3.2 Autoimmune Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Biogen Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Amgen
6.4.2 Autoimmune Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Amgen Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Pfizer
6.5.2 Autoimmune Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Pfizer Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 F. Hoffmann-La Roche
6.6.2 Autoimmune Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 F. Hoffmann-La Roche Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 AstraZeneca
6.7.2 Autoimmune Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AstraZeneca Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 GSK
6.8.2 Autoimmune Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 GSK Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.2 Autoimmune Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Boehringer Ingelheim
6.10.2 Autoimmune Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Boehringer Ingelheim Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Eli Lilly
6.12 Novartis
6.13 Sanofi
6.14 Takeda Pharmaceuticals
6.15 Vertex Pharmaceuticals
6.16 Eisai
6.17 Lexicon Pharmaceuticals
6.18 KaloBios Pharmaceuticals
6.19 Can-Fite BioPharma
6.20 Antares Pharma
6.21 Acorda Therapeutics

7 Autoimmune Drugs Manufacturing Cost Analysis
7.1 Autoimmune Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Autoimmune Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Autoimmune Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Autoimmune Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Autoimmune Drugs Market Forecast (2017-2022)
11.1 United States Autoimmune Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Autoimmune Drugs Sales Forecast by Type (2017-2022)
11.3 United States Autoimmune Drugs Sales Forecast by Application (2017-2022)
11.4 Autoimmune Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Autoimmune Drugs
Table Classification of Autoimmune Drugs
Figure United States Sales Market Share of Autoimmune Drugs by Type in 2015
Figure Rheumatoid Arthritis (RA) Picture
Figure Multiple Sclerosis (MS) Picture
Figure Psoriasis Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Ankylosing Spondylitis (AS) Picture
Figure Systemic Lupus Erythematosus (SLE) Picture
Table Application of Autoimmune Drugs
Figure United States Sales Market Share of Autoimmune Drugs by Application in 2015
Figure Hospital Examples
Figure Clinic Examples
Figure United States Autoimmune Drugs Sales and Growth Rate (2012-2022)
Figure United States Autoimmune Drugs Revenue and Growth Rate (2012-2022)
Table United States Autoimmune Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Autoimmune Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Autoimmune Drugs Sales Share by Manufacturers
Figure 2016 Autoimmune Drugs Sales Share by Manufacturers
Table United States Autoimmune Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Autoimmune Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Autoimmune Drugs Revenue Share by Manufacturers
Table 2016 United States Autoimmune Drugs Revenue Share by Manufacturers
Table United States Market Autoimmune Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Autoimmune Drugs Average Price of Key Manufacturers in 2015
Figure Autoimmune Drugs Market Share of Top 3 Manufacturers
Figure Autoimmune Drugs Market Share of Top 5 Manufacturers
Table United States Autoimmune Drugs Sales by States (2012-2017)
Table United States Autoimmune Drugs Sales Share by States (2012-2017)
Figure United States Autoimmune Drugs Sales Market Share by States in 2015
Table United States Autoimmune Drugs Revenue and Market Share by States (2012-2017)
Table United States Autoimmune Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Autoimmune Drugs by States (2012-2017)
Table United States Autoimmune Drugs Price by States (2012-2017)
Table United States Autoimmune Drugs Sales by Type (2012-2017)
Table United States Autoimmune Drugs Sales Share by Type (2012-2017)
Figure United States Autoimmune Drugs Sales Market Share by Type in 2015
Table United States Autoimmune Drugs Revenue and Market Share by Type (2012-2017)
Table United States Autoimmune Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Autoimmune Drugs by Type (2012-2017)
Table United States Autoimmune Drugs Price by Type (2012-2017)
Figure United States Autoimmune Drugs Sales Growth Rate by Type (2012-2017)
Table United States Autoimmune Drugs Sales by Application (2012-2017)
Table United States Autoimmune Drugs Sales Market Share by Application (2012-2017)
Figure United States Autoimmune Drugs Sales Market Share by Application in 2015
Table United States Autoimmune Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Autoimmune Drugs Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AbbVie Autoimmune Drugs Sales Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Autoimmune Drugs Sales Market Share (2012-2017)
Table Biogen Basic Information List
Table Biogen Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biogen Autoimmune Drugs Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Autoimmune Drugs Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Autoimmune Drugs Sales Market Share (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffmann-La Roche Autoimmune Drugs Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Autoimmune Drugs Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Autoimmune Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Autoimmune Drugs Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Autoimmune Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Autoimmune Drugs Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Novartis Basic Information List
Table Sanofi Basic Information List
Table Takeda Pharmaceuticals Basic Information List
Table Vertex Pharmaceuticals Basic Information List
Table Eisai Basic Information List
Table Lexicon Pharmaceuticals Basic Information List
Table KaloBios Pharmaceuticals Basic Information List
Table Can-Fite BioPharma Basic Information List
Table Antares Pharma Basic Information List
Table Acorda Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Autoimmune Drugs
Figure Manufacturing Process Analysis of Autoimmune Drugs
Figure Autoimmune Drugs Industrial Chain Analysis
Table Raw Materials Sources of Autoimmune Drugs Major Manufacturers in 2015
Table Major Buyers of Autoimmune Drugs
Table Distributors/Traders List
Figure United States Autoimmune Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Autoimmune Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Autoimmune Drugs Production Forecast by Type (2017-2022)
Table United States Autoimmune Drugs Consumption Forecast by Application (2017-2022)
Table United States Autoimmune Drugs Sales Forecast by States (2017-2022)
Table United States Autoimmune Drugs Sales Share Forecast by States (2017-2022)